» Articles » PMID: 29297237

Species-specific Differences in Regulation of Macrophage Inflammation by the C3a-C3a Receptor Axis

Overview
Journal Innate Immun
Publisher Sage Publications
Date 2018 Jan 4
PMID 29297237
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Complement is an important arm of the innate immune system. Recent studies have shown that products of complement pathway activation can interact directly with other innate immune signaling molecules, including TLRs and inflammasome family members, during some infectious and chronic inflammatory disorders. Activation of the complement system generates anaphylatoxins, such as C3a and C5a, which modulate inflammation. However, the biological effects of interactions between the anaphylatoxins with their receptors may vary across species. In this study, we demonstrate that human complement and rat complement differ in the way they modulate the inflammatory response to the human pathogen, Neisseria gonorrhoeae, as well as purified pathogen-associated ligands, such as LPS. While rat serum down-regulates MyD88-dependent pro-inflammatory cytokine responses in macrophages, human serum has no effect, or in some cases an enhancing effect. Further, the inhibitory effect of rat serum on otherwise pro-inflammatory stimuli is mediated by complement, specifically C3a-C3a receptor interactions, via an undefined signaling mechanism that down-regulates the transcription factor, NF-κB and NLRP3 inflammasome-mediated caspase-1 activation. This study highlights important functional differences between rodent and human complement that could explain some of the differences in immune responses between these two species. Understanding the crosstalk between complement and other arms of the innate immune system will facilitate the development of better anti-inflammatory therapeutics.

Citing Articles

Human Amnion-Derived Mesenchymal Stromal Cells: A New Potential Treatment for Carbapenem-Resistant in Decompensated Cirrhosis.

Pampalone M, Vitale G, Gruttadauria S, Amico G, Iannolo G, Douradinha B Int J Mol Sci. 2022; 23(2).

PMID: 35055040 PMC: 8775978. DOI: 10.3390/ijms23020857.


Complement C3 Aggravates Post-epileptic Neuronal Injury Via Activation of TRPV1.

Jiang G, Shao L, Kong S, Zeng M, Cheng J, Chen T Neurosci Bull. 2021; 37(10):1427-1440.

PMID: 34309810 PMC: 8490607. DOI: 10.1007/s12264-021-00750-4.


Perisynaptic Schwann cells phagocytose nerve terminal debris in a mouse model of Guillain-Barré syndrome.

Cunningham M, Meehan G, Robinson S, Yao D, McGonigal R, Willison H J Peripher Nerv Syst. 2020; 25(2):143-151.

PMID: 32250537 PMC: 8299349. DOI: 10.1111/jns.12373.


The protective roles of NLRP6 in intestinal epithelial cells.

Yin J, Sheng B, Yang K, Sun L, Xiao W, Yang H Cell Prolif. 2018; 52(2):e12555.

PMID: 30515917 PMC: 6496424. DOI: 10.1111/cpr.12555.

References
1.
Ricklin D, Lambris J . Complement in immune and inflammatory disorders: pathophysiological mechanisms. J Immunol. 2013; 190(8):3831-8. PMC: 3623009. DOI: 10.4049/jimmunol.1203487. View

2.
Nachamkin I, Cannon J, Mittler R . Monoclonal antibodies against Neisseria gonorrhoeae: production of antibodies directed against a strain-specific cell surface antigen. Infect Immun. 1981; 32(2):641-8. PMC: 351495. DOI: 10.1128/iai.32.2.641-648.1981. View

3.
Duncan J, Gao X, Huang M, OConnor B, Thomas C, Willingham S . Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome. J Immunol. 2009; 182(10):6460-9. PMC: 2722440. DOI: 10.4049/jimmunol.0802696. View

4.
Takabayashi T, Vannier E, Clark B, Margolis N, Dinarello C, Burke J . A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis. J Immunol. 1996; 156(9):3455-60. View

5.
Sahu A, Kay B, Lambris J . Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library. J Immunol. 1996; 157(2):884-91. View